Abstract
Human eosinophil-derived neurotoxin (EDN) or RNase 2, found in the non-core matrix of eosinophils is a ribonuclease belonging to the Ribonuclease A superfamily. EDN manifests a number of bioactions including neurotoxic and antiviral activities, which are dependent on its ribonuclease activity. The core of the catalytic site of EDN contains various base and phosphate-binding subsites. Unlike many members of the RNase A superfamily, EDN contains an additional non-catalytic phosphate-binding subsite, P−1. Although RNase A also contains a P−1 subsite, the composition of the site in EDN and RNase A is different. In the current study we have generated site-specific mutants to study the role of P−1 subsite residues Arg36, Asn39, and Gln40 of EDN in its catalytic activity. The individual mutation of Arg36, Asn 39, and Gln40 resulted in a reduction in the catalytic activity of EDN on poly(U) and poly(C). However, there was no change in the activities on yeast tRNA and dinucleotide substrates. The study shows that the P−1 subsite is crucial for the ribonucleolytic activity of EDN on polymeric RNA substrates.




Similar content being viewed by others
References
Beintema JJ, Breukelman HJ, Carsana A, Furia A (1997) Evolution of vertebrate ribonucleases: ribonuclease A superfamily. In: D’Alessio G, Riordan JF (eds) Ribonucleases: structure and functions. Academic Press, New York, pp 245–269
Hamann KJ, Barker RL, Loegering DA, Pease LR, Gleich GJ (1989) Sequence of human eosinophil-derived neurotoxin cDNA: identity of deduced amino acid sequence with human nonsecretory ribonucleases. Gene 83:161–167
Hamann KJ, Ten RM, Loegering DA, Jenkins RB, Heise MT, Schad CR, Pease LR, Gleich GJ, Barker RL (1990) Structure and chromosome localization of the human eosinophil-derived neurotoxin and eosinophil cationic protein genes: evidence for intronless coding sequences in the ribonuclease gene superfamily. Genomics 7:535–546
Weller PF (1991) The immunobiology of eosinophils. N Engl J Med 324:1110–1118
Peters MS, Rodriguez M, Gleich GJ (1986) Localization of human eosinophil granule major basic protein, eosinophil cationic protein and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest 54:656–662
Rosenberg HF, Ackerman SJ, Tenen DG (1989) Human eosinophil cationic protein: molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. J Exp Med 170:163–176
Rosenberg HF, Tenen DG, Ackerman SJ (1989) Molecular cloning of human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. Proc Natl Acad Sci U S A 86:4460–4464
Sorrentino S, Glitz DG, Hamann KJ, Loegering DA, Checkel JL, Gleich GJ (1992) Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity. J Biol Chem 267:14859–14865
Domachowske JB, Dyer KD, Bonville CA, Rosenberg HF (1998) Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J Infect Dis 177:1458–1464
Domachowske JB, Bonville CA, Dyer KD, Rosenberg HF (1998) Evolution of antiviral activity in the ribonuclease A gene superfamily: evidence for a specific interaction between eosinophil-derived neurotoxin (EDN/RNase2) and respiratory syncytial virus. Nucleic Acids Res 26:5327–5332
Domachowske JB, Dyer KD, Adams AG, Leto TL, Rosenberg HF (1998) Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res 26:3358–3363
Mosimann SC, Newton DL, Youle RJ, James MNG (1996) X-ray crystallographic structure of recombinant eosinophil-derived neurotoxin at 1.83Å resolution. J Mol Biol 260:540–552
Swaminathan GJ, Holloway DE, Veluraja K, Acharya KR (2002) Atomic resolution (0.98Å) structure of eosinophil-derived neurotoxin. Biochemistry 41:3341–3352
Gullberg U, Widegren B, Arnason U, Egesten A, Olsson I (1986) The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity. Biochem Biophy Res Commun 139:1239–1242
Slifman NR, Loegering DA, McKean DJ, Gleich GJ (1986) Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol 137:2913–2917
Sorrentino S, Libonati M (1994) Human pancreatic-type and non-pancreatic type ribonucleases: a direct side-by-side comparison of their catalytic properties. Arch Biochem Biophys 312:340–348
Richards FM, Wyckoff HW (1971) Bovine pancreatic ribonuclease. In: Boyer PD (ed) The enzymes, vol 4. Academic Press, New York, pp 647–806
Boix E, Nogues MV, Schein CH, Benner SA, Cuchillo CM (1994) Reverse transphosphorylation by ribonuclease A needs an intact p2-binding site. Point mutations at Lys-7 and Arg-10 alter the catalytic properties of the enzyme. J Biol Chem 269:2529–2534
Nogues MV, Vilanova M, Cuchillo CM (1995) Bovine pancreatic ribonuclease A as a model of an enzyme with multiple binding sites. Biochim Biophys Acta 1253:16–24
Fisher BM, Grilley JE, Raines RT (1998) A new remote subsite in Ribonuclease A. J Biol Chem 273:34134–34138
Pares X, Nogues MV, de Llorens R, Cuchillo CM (1991) Structure and function of ribonuclease A binding subsites. Essays Biochem 26:89–103
Leonidas DD, Boix E, Pril R, Suzuki M, Turton R, Minson K, Swaminathan GJ, Youle RJ, Acharya KR (2001) Mapping the ribonucleolytic active site of eosinophil-derived neurotoxin (EDN): high resolution crystal structures of EDN complexes with adenylic nucleotide inhibitors. J Biol Chem 276:15009–15017
Rosenberg HF (1998) The eosinophil ribonucleases. Cell Mol Life Sci 54:795–803
Kunkel TA, Roberts JD, Zakour RA (1987) Rapid and efficient site-specific mutagenesis without phenotypic selection. Meth Enzymol 154:367–382
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 74:5463–5467
Buchner J, Pastan I, Brinkmann U (1992) A method for increasing the yield of properly folded recombinant fusion proteins: single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal Biochem 205:263–270
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 7:248–254
Blank A, Sugiyama RH, Dekker CA (1982) Activity staining of nucleolytic enzymes after sodium dodecyl sulfate-polyacrylamide gel electrophoresis: use of aqueous isopropanol to remove detergent from gels. Anal Biochem 120:267–275
Bond MD (1988) An in vitro binding assay for angiogenin using a placental ribonuclease inhibitor. Anal Biochem 173:166–173
Gaur D, Swaminathan S, Batra JK (2001) Interaction of human pancreatic ribonuclease with human ribonuclease inhibitor: generation of inhibitor-resistant cytotoxic variants. J Biol Chem 276:24978–24984
Tarragona-Fiol A, Eggelte HJ, Harbron S, Sanchez E, Taylorson CJ, Ward JM, Rabin BR (1993) Identification by site-directed mutagenesis of amino acids in the B2 subsite of bovine pancreatic ribonuclease A. Protein Eng 6:901–906
Baker MD, Holloway DE, Swaminathan GJ, Acharya KR (2006) Crystal structures of eosinophil-derived neurotoxin (EDN) in complex with the inhibitors 5′-ATP, Ap3A, Ap4A, and Ap5A. Biochemistry 45:416–426
Acknowledgments
This work was supported by grants to the National Institute of Immunology from the Department of Biotechnology, Government of India, and a grant (SP/SO/BB-01/2003) to JKB from the Department of Science and Technology, Government of India. DS, DS, and PD are Senior Research Fellows of the Council of Scientific and Industrial Research, India.
Author information
Authors and Affiliations
Corresponding author
Additional information
Deepa Sikriwal and Divya Seth contributed equally to this work.
Rights and permissions
About this article
Cite this article
Sikriwal, D., Seth, D., Dey, P. et al. Human eosinophil-derived neurotoxin: involvement of a putative non-catalytic phosphate-binding subsite in its catalysis. Mol Cell Biochem 303, 175–181 (2007). https://doi.org/10.1007/s11010-007-9471-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-007-9471-0


